Stock Events

Stock Events

Kairos Pharma (KAPA) Q2 2026 Earnings

May 13Confirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.08

-0.06

-0.04

-0.02

Details

Expected EPS

-0.08

Actual EPS

-0.08

Surprise EPS

0

Surprise Percent

+0%

Description

⁨Kairos Pharma⁩ (⁦KAPA⁩) has reported earnings of ⁦-0.08⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.